Amryt Pharma Plc Profit Margin

The latest profit margin for AMYT is -8.19% as of September 2022. That compares with -41.64% in the prior-year period — up 80.3% year over year. That is below the Healthcare sector average of 14.34%. Investors often review this figure alongside Amryt Pharma Plc's historical trend and sector peers before judging valuation or financial health.

Over the past year, AMYT's profit margin moved from -41.64% to -8.19% — a 80.3% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Amryt Pharma Plc's valuation or profitability profile.

Against Healthcare companies, AMYT currently prints -8.19% for profit margin, while the sector average sits near 14.34%. That is roughly 157.1% below the sector mean. Large gaps often invite a closer look at Amryt Pharma Plc's growth, margins, and balance sheet.

Profit Margin shows how effectively Amryt Pharma Plc converts resources into returns. At -8.19%, AMYT may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -41.64% in the prior-year period — up 80.3% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting AMYT's profit margin (-8.19%), review year-over-year change from -41.64%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.